May 22 (Reuters) - Avecho Biotechnology Ltd (AVE) :
- SIGNED A LICENSING AND DEVELOPMENT AGREEMENT WITH ARTHUR GROUP LLC
- AGREEMENT INCLUDES RIGHTS TO FIVE SEPARATE ONCOLOGY PRODUCTS, REPRESENTING COMBINED US MARKET OF US$2.92 BILLION
- AGREEMENT FOR FOR DEVELOPMENT OF A SERIES OF LEADING CANCER DRUGS
- UNDER DEAL, AVECHO WILL RECEIVE 30% OF REVENUE FROM LICENSING AND 30% OF NET PROFIT FROM COMMERCIALISATION OF PRODUCTS
News: AVE Avecho Biotechnology Signs Licensing And Development Agreement With Arthur Group Llc
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.366K | 455.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 99145902 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 22467224 | 7 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |